Tudor Investment Corp’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-122,930
| Closed | -$409K | – | 1895 |
|
|
2025
Q1 | $409K | Buy |
+122,930
| New | +$409K | ﹤0.01% | 1265 |
|
|
2024
Q4 | – | Sell |
-218,927
| Closed | -$2.06M | – | 1819 |
|
|
2024
Q3 | $2.06M | Sell |
218,927
-80,958
| -27% | -$760K | 0.01% | 749 |
|
|
2024
Q2 | $2.41M | Buy |
299,885
+55,269
| +23% | +$443K | 0.01% | 651 |
|
|
2024
Q1 | $3.63M | Buy |
244,616
+211,468
| +638% | +$3.13M | 0.02% | 502 |
|
|
2023
Q4 | $269K | Buy |
+33,148
| New | +$269K | ﹤0.01% | 1283 |
|
|
2023
Q3 | – | Sell |
-115,277
| Closed | -$812K | – | 1703 |
|
|
2023
Q2 | $812K | Buy |
115,277
+57,750
| +100% | +$407K | 0.01% | 975 |
|
|
2023
Q1 | $351K | Sell |
57,527
-37,102
| -39% | -$226K | 0.01% | 1234 |
|
|
2022
Q4 | $605K | Buy |
94,629
+15,849
| +20% | +$101K | 0.01% | 1056 |
|
|
2022
Q3 | $755K | Sell |
78,780
-11,714
| -13% | -$112K | 0.02% | 943 |
|
|
2022
Q2 | $999K | Buy |
90,494
+60,124
| +198% | +$664K | 0.03% | 807 |
|
|
2022
Q1 | $506K | Sell |
30,370
-57,162
| -65% | -$952K | 0.01% | 1103 |
|
|
2021
Q4 | $1.67M | Buy |
87,532
+39,550
| +82% | +$755K | 0.03% | 679 |
|
|
2021
Q3 | $1.18M | Buy |
+47,982
| New | +$1.18M | 0.02% | 800 |
|
|
2021
Q2 | – | Sell |
-150,091
| Closed | -$4.75M | – | 1637 |
|
|
2021
Q1 | $4.75M | Buy |
+150,091
| New | +$4.75M | 0.1% | 187 |
|
|
2020
Q3 | – | Sell |
-31,938
| Closed | -$877K | – | 1400 |
|
|
2020
Q2 | $877K | Buy |
+31,938
| New | +$877K | 0.04% | 511 |
|
|
2017
Q4 | – | Sell |
-19,000
| Closed | -$147K | – | 1154 |
|
|
2017
Q3 | $147K | Buy |
+19,000
| New | +$147K | ﹤0.01% | 977 |
|
|
2015
Q2 | – | Sell |
-18,225
| Closed | -$221K | – | 1533 |
|
|
2015
Q1 | $221K | Buy |
+18,225
| New | +$221K | 0.01% | 1228 |
|